$UnitedHealth(UNH)$  sharing is caring

📈 UNH Breakout: Buffett’s Healthcare Bet — $400 Next? UnitedHealth ($UnitedHealth(UNH)$  $UnitedHealth(UNH)$  ) just smashed through its $320 resistance, and the momentum is catching fire. After reaffirming its 2025 earnings outlook — with EPS projected at $16.00+ and revenue guided at $445.5B–$448B — Wall Street is getting even bolder. Consensus estimates sit slightly higher, with $16.24 EPS on ~$448.2B revenue. The stock’s rally has reignited the debate: is UNH a defensive giant quietly transforming into a growth story, or is this the moment to lock in profits before the climb stalls? Add in the fact that Warren Buffett loaded up $1.6B at an average $314 — and the story gets even juici

$UnitedHealth(UNH)$ 💊📈🛡️ $UNH Breakout With Value Compounding 💊📈🛡️ I see UnitedHealth breaking out as a value compounder hiding in plain sight. Despite people served falling (–4.08% YoY), Optum Health growth offsets declines, driving superior cash returns. At just 15.2x P/E and a 7.92% FCF yield, the setup is compelling. Breakout over $350 now sets short-term target $370 and medium-term path toward $395–400. Support holds at $345–347, and history shows UNH breakouts of this structure deliver 12–15% measured moves. Happy trading ahead, Cheers, BC 📈🚀🍀🍀🍀

$UnitedHealth(UNH)$   Support for a move toward $400: 1. Strong fundamentals: UnitedHealth has diversified business (healthcare plans + services, via Optum etc.), strong cash flow, and decent earnings growth. Those help build a base for higher valuations.  2. Recent upgrades and raised targets: Some upgrades (like at Truist) show increasing confidence. These tend to help with investor sentiment.  3. Room for multiple expansion: If UNH can demonstrate margin improvement, reduce regulatory risk, or show accelerating growth, the market may reward it with a higher P/E, pushing the price up. Challenges / what needs to go right / risk factors: • Regulatory risk is nontrivial for big health insurers. Changes in Medicare/Medicaid policy, reimbu

UnitedHealth Group is a stock in need of a second opinion. Trading at $353, down more than 40 per cent from its 52-week high, it sits at a valuation multiple of just 15 times earnings — modest for a company that still pulls in over $420 billion in annual revenue. The market is clearly pricing in lasting damage. I think the case is more nuanced. If Optum can recover margins, if Medicare Advantage scrutiny is contained, and if capital returns are deployed with conviction, then the climb back to $400 is achievable. Networks align: Optum’s reach could redraw healthcare’s balance sheet Optum’s margin pulse Optum has become the engine that keeps $UnitedHealth(UNH)$ competitive. It now accounts for nearly half of operating earnings, yet recent quarters ha

$UnitedHealth(UNH)$  yes will definitely reach $400

UnitedHealth continues to jump after the health insurer reaffirmed its full-year 2025 earnings outlook.The company said it continues to expect adjusted earnings of at least $16.00 per share with revenue in the range of $445.5 billion to $448.0 billion. Wall Street currently forecasts earnings of $16.24 per share on revenue near $448.2 billion.After breaking the key resistance level of $320, is UNH hitting the short term peak?Have you jumped on the wagon with Buffett?🎁Special Notes: Whoever showed up on the” What the Tigers Say” column will receive 100 Tiger Coins and an exclusive interview invitation to honor your contribution.Click titles to read the full analysis:1. @TwoDeMoon:Key Points:This is a defensive and fundamental / value pi

$联合健康(UNH)$   I would like to say: "Thanks        Warren  Buffett!"

$UnitedHealth(UNH)$  this is a defensive and fundamental / value pick. For those who bought at 300 or below, congrats! Still lots of runway to go!!! $400 price target before end 2026

$UnitedHealth(UNH)$ UnitedHealth Group (UNH) shares surged after reaffirming its 2025 earnings outlook of at least $16 per share on revenue of $445.5-$448 billion, slightly below Wall Street's $16.24 EPS and $448.2 billion forecast, but signaling confidence amid healthcare challenges. The stock, a Buffett favorite through Berkshire Hathaway's 1.1 million share stake, trades at $320.25, up 8.76% recently, with analysts maintaining a Buy rating and $387.63 average target. With the S&P 500 at 6,520, Nasdaq at 21,950, and Bitcoin at $123,456, the VIX at 14.12 reflects calm amid oil at $74.50/barrel. Posts found on X buzz with "UNH rebound" optimism, but tariff fears linger. This deep dive explores the reaffirmation, current stance, future prospects

$UnitedHealth(UNH)$   UnitedHealth (UNH) Current Situation Guidance reaffirmed: Management reiterated ≥ $16.00 EPS and $445.5B–$448B revenue for FY2025. This is broadly in line with Wall Street’s expectations, signalling stability. Market reaction: Shares broke through the $320 resistance level, which had been a ceiling for months. Technical traders view this as a bullish breakout. Valuation context: At ~$320, UNH trades around 20x forward earnings—not cheap, but reasonable for a defensive healthcare leader with consistent growth. --- Short-Term View Breakout risk: After a strong run, stocks often pause or consolidate as early buyers take profits. Catalysts ahead: Medicare Advantage enrolments, medical cost trend

$UnitedHealth(UNH)$ $UnitedHealth(UNH)$   📈 UNH Breakout: Buffett’s Healthcare Bet Roars Past $320 — Buy or Bail? UnitedHealth Group (UNH) has smashed through the $320 resistance level, sending a clear signal to Wall Street: healthcare’s quiet giant isn’t done yet. With a reaffirmed 2025 outlook of $16+ EPS and revenue guidance of $445B–$448B, the numbers are steady. Wall Street’s consensus is even bolder, penciling in $16.24 EPS on ~$448.2B revenue. But here’s what’s really fueling excitement: Warren Buffett’s $1.6B stake. When the Oracle of Omaha places a billion-dollar bet, retail investors notice. UNH suddenly looks less like a slow-moving insurer and more like a

$UnitedHealth(UNH)$ $Alibaba(BABA)$ $SPDR S&P 500 ETF Trust(SPY)$ I’m fully convinced $UNH is setting up for one of the most asymmetric upside trades of the year. With Berkshire’s stake anchoring conviction, Congressional buys lighting the fuse, shorts overloaded, and fundamentals stabilizing, this looks less like a recovery and more like a full-scale rerating. 🧮 Discounted Cashflow Conviction I’ve run the DCF, and the result is decisive. Equity value per share comes in at $580.03, nearly 70% upside from here. Present value of the next decade of cashflows plus terminal value makes the current market price deeply disconnected from intrinsic worth. At an 8.5% dis

“Markets gave their best shot with Tech — but valuations stretched and momentum cooled. Now, capital is rotating into Healthcare, with defensives like UnitedHealth leading the narrative. The expected story finally plays out:$UnitedHealth(UNH)$  

1. $Oscar Health, Inc.(OSCR)$ Still holding and breakout looks strong. Resistance at $20–$21 is where you could trim profits. If price clears $20–$23, a level rejected 4 times before, we could see a 6-month rally toward $40. I’ll likely take partial profits but keep 50% in case it runs.Image2. $UnitedHealth(UNH)$ Smart money zone held to perfection 🟣Break above $320 opens the door for a move back into the $360–$400 range. Saving some capital in case price pulls back $280 one last time.Image3. $Robinhood(HOOD)$ HOOD — I was dead wrong on this one 😑But even now, I still don’t see it as a buy. You’re paying a massive premium.Some calls age like 🍷... others like 🥛Imag

$UnitedHealth(UNH)$  

$UNH 20250919 290.0 PUT$ UNH getting bullish, selling a put for premium